Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | FABP7 | O15540 | 2/20 | 0.44 |
| ▸ | FABP5 | Q01469 | 2/20 | 0.44 |
| ▸ | LNPEP | Q9UIQ6 | 2/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 7/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 7/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 6/20 | 0.42 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31423769 | 1.00 | EPHX2 (0.53) | EPHX2KMT2AFABP7FABP5LNPEP | |
| SCHEMBL29547309 | 1.00 | EPHX2 (0.53) | EPHX2KMT2AFABP7FABP5LNPEP | |
| SCHEMBL17413389 | 0.91 | EPHX2 (0.53) | EPHX2KMT2AFABP7FABP5HDAC1 | |
| SCHEMBL25397265 | 0.89 | EPHX2 (0.56) | EPHX2KMT2AFABP7FABP5CASP3 | |
| SCHEMBL30522780 | 0.89 | EPHX2 (0.56) | EPHX2KMT2AFABP7FABP5CASP3 | |
| SCHEMBL31423768 | 0.88 | EPHX2 (0.48) | EPHX2KMT2AFABP7FABP5CASP3 | |
| SCHEMBL3209502 | 0.87 | EPHX2 (0.57) | EPHX2KMT2AFABP7FABP5CASP3 | |
| SCHEMBL570236 | 0.86 | EPHX2 (0.53) | EPHX2KMT2ACASP3 | |
| SCHEMBL29546978 | 0.85 | EPHX2 (0.52) | EPHX2KMT2AFABP7FABP5CASP3 | |
| SCHEMBL29547060 | 0.85 | EPHX2 (0.52) | EPHX2KMT2AFABP7FABP5CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117377759-A | Self-purified nucleic acid-encoded libraries | 约尔格·谢尔曼 | 2024-01-09 | — | — | CN | disclosed |
| US-20230357757-A1 | SELF-PURIFIED NUCLEIC ACID ENCODED LIBRARIES | PETROV, DIMITAR (CH) | 2023-11-09 | — | — | US | disclosed |
| US-20160002286-A1 | CHEMICAL PREPARATION OF UBIQUITIN THIOESTERS AND MODIFICATIONS THEREOF | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY | 2016-01-07 | — | — | US | disclosed |
| US-20160002286-A1 | CHEMICAL PREPARATION OF UBIQUITIN THIOESTERS AND MODIFICATIONS THEREOF | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY | 2016-01-07 | — | — | US | disclosed |
| US-9175053-B2 | Chemical preparation of ubiquitin thioesters and modifications thereof | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2015-11-03 | — | — | US | disclosed |
| US-9175053-B2 | Chemical preparation of ubiquitin thioesters and modifications thereof | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2015-11-03 | — | — | US | disclosed |
| US-20130041132-A1 | CHEMICAL PREPARATION OF UBIQUITIN THIOESTERS AND MODIFICATIONS THEREOF | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2013-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160002286-A1 | CHEMICAL PREPARATION OF UBIQUITIN THIOESTERS AND MODIFICATIONS THEREOF | OTUB1, USP28, PTMS | EPHX2 1481/4885KMT2A 738/4885FABP7 2118/4885 |
| US-20130041132-A1 | CHEMICAL PREPARATION OF UBIQUITIN THIOESTERS AND MODIFICATIONS THEREOF | OTUB1, USP28, PTMS | EPHX2 1481/4885KMT2A 738/4885FABP7 2118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.